Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma
NCT01053949Phase 2Completed
- Sponsor
- CHU de Lille
- Start
- Oct 2009
- Primary completion
- Apr 2014
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of pomalidomide in multiple myeloma (MM), sponsored by CHU de Lille. Started Oct 2009; status: completed.
02
Drugs
pomalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01053949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01053949.